Global /China /Healthcare /Drug Manufacturers - General /000788

PKU HealthCare Corp.,Ltd.

000788

• SHE: 000788 • Delayed

6.12CNY -2.1%

0.9016 USD

As of 4 July 2026, PKU HealthCare Corp.,Ltd. has a market cap of $548.77M USD, ranking #14491 globally and #4505 in China. It ranks #1286 in the Healthcare sector, and #478 in the Drug Manufacturers - General industry.

Global Rank

14491

1d: -13

1w: -

1m: -

Country Rank

4505

1d: -5

1w: -

1m: -

Sector Rank

1286

1d: +2

1w: -

1m: -

Industry Rank

478

1d: 0

1w: -

1m: -

Key Stats

Market Cap

$548.77MUSD

3.72B CNY

Enterprise Value

$419.48MUSD

2.85B CNY

Revenue (TTM)

$176.08MUSD

1.2B CNY

EBITDA (TTM)

$24.29MUSD

164.89M CNY

Net Income (TTM)

$9.46MUSD

64.24M CNY

EBITDA Margin

14%

Profit Margin

5.4%

PE Ratio

58.0

PS Ratio

3.1

PB Ratio

2.5

EV/EBITDA

17.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ping Dong Yuan open_in_new

Employees

772

Founded

1965

Website

pku-hc.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.1%	-3%	3.6%	-3.3%	-0.8%	0.2%	9.3%	-13%	-15%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000788 北大医药股份有限公司 Class A ISIN: CNE0000008M0 Shares Out.: Shares Outstanding: 595.987M¹ Shares Float: 568.371M² TV: TradingView: SZSE: 000788 SA: Stock Analysis: SHE: 000788 YF: Yahoo Finance: 000788.SZ GF: Google Finance: SHE: 000788 BA: Barron's: 000788 MS: Morningstar: XSHE: 000788	6.12 CNY	TV: TradingView: SZSE: 000788 SA: Stock Analysis: SHE: 000788 YF: Yahoo Finance: 000788.SZ GF: Google Finance: SHE: 000788 BA: Barron's: 000788 MS: Morningstar: XSHE: 000788

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PKU HealthCare Corp.,Ltd.

PKU HealthCare Corp.,Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers products in various categories, including cardiovascular and cerebrovascular, antimicrobial, antipyretic and analgesic, digestive system, oncology, anti-allergic, blood sugar and immunity regulation, mental disorder, and blood volume expansion. It also provides tumor screening, health management, diagnosis, and treatment services. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1965 and is headquartered in Chongqing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.76B 364.89B CNY 10K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.55B 336.36B CNY 9K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.5B 223.48B HKD 5K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.78B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.48B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 139K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 100K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 66K%	97.4	United States
Roche Holding AG SIX: RO	$318.9B 256.25B CHF 58K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.77B 215.59B GBP 52K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 50K%	15.1	United States

chevron_leftBack